Trial Profile
A Phase 1, Dose-Ranging Pharmacokinetic Study Comparing Investigational Oral Formulation with the Current Intravenous Formulation of Edaravone
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Dec 2018
Price :
$35
*
At a glance
- Drugs Edaravone (Primary) ; Edaravone
- Indications Amyotrophic lateral sclerosis
- Focus Pharmacokinetics
- 02 Dec 2018 New trial record
- 15 Nov 2018 Results presented in a Media Release
- 15 Nov 2018 According to a Mitsubishi Tanabe Pharma America media release, data collection from this study is ongoing and the latest results and its anticipated development plan will be presented at the upcoming Symposium.